4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-060680
Chief Tech. Operations Officer sold 1,500 shares at an average $41.14 ($61,704)
- Chief Tech. Operations Officer acquired 1,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Newell Joe Chief Tech. Operations Officer | 2018-12-03 | Option exercise | +1,500 | $20.40 | $30,600 | 33,358 | D |
| Newell Joe Chief Tech. Operations Officer | 2018-12-03 | Sale | −973 | $40.61 | $39,514 | 32,385 | D |
| Newell Joe Chief Tech. Operations Officer | 2018-12-03 | Sale | −400 | $41.97 | $16,788 | 31,985 | D |
| Newell Joe Chief Tech. Operations Officer | 2018-12-03 | Sale | −127 | $42.54 | $5,403 | 31,858 | D |
| Derivatives | |||||||
| Newell Joe Chief Tech. Operations Officer | 2018-12-03 | Option exercise · Employee Stock Option (Right to Buy) | −1,500 | 72,500 | D | ||
| Open-market sales · 1,500 sh · avg $41.14 · $61,704 | |||||||
Loading xslF345X03/doc4.xml…